Oculis Holding AG - Ordinary Shares, par value CHF 0.01 per share (OCS)

CUSIP: H5870P102

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 6 signals
Share change
+4,525,547
SEC-reported price per share
$19.97
Number of holders
40
Value change
+$90,374,744
Number of buys
27
Number of sells
5
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
58,900,797

Security key

H5870P102

Report period

Q4 2025

Institutions

40

Top holders

10

Ownership snapshot

Top reported holders of OCS - Oculis Holding AG - Ordinary Shares, par value CHF 0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Pivotal bioVenture Partne...
Disclosed value leader
EQT Fund Management S.a r.l.
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G 13F Lead comparable stake: 4.9% 13D/G row: Pivotal bioVenture Partners Fund I, L.P. Showing 1-6 of 15 holder rows.

Quick read

Pivotal bioVenture Partners Fund I, L.P. leads the comparable SEC ownership view at 4.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Pivotal bioVenture Partners Fund I, L.P.'s linked filing trail.
Comparable ownership Top 5
Pivotal bioVenture Partners Fund ... 4.9%
EQT Fund Management S.a r.l. 10%
Pivotal bioVenture Partners Inves... 3.9%
Aberdeen Group plc 2.1%
Nan Fung Group Holdings Ltd 0.87%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Pivotal bioVenture Partners Fund I, L.P.
13D/G
Nan Fung Group Holdings Limited
4.9%
$49,946,544
2,815,476 shares
$0 30 Sep 2025
EQT Fund Management S.a r.l.
13F
Company
13F
10%
$103,727,169
5,900,294 shares
30 Sep 2025
Pivotal bioVenture Partners Investment Advisor LLC
13F
Company
13F
3.9%
$40,447,607
2,300,774 shares
30 Sep 2025
Aberdeen Group plc
13F
Company
13F
2.1%
$22,217,800
1,253,119 shares
30 Sep 2025
Nan Fung Group Holdings Ltd
13F
Company
13F
0.87%
$9,048,461
514,702 shares
30 Sep 2025
SR ONE CAPITAL MANAGEMENT, LP
13F
Company
13F
0.55%
$5,669,550
322,500 shares
30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
40
Shares
18,020,789
Rows available
40
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
20
Q4 2025 holders
40
Holder diff
20
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .